Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Cardiovascular Surgery

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1605573

This article is part of the Research TopicSurgical Revascularization of the Ischemic Myocardium in the third millenniumView all 4 articles

Impact of Left Anterior Descending Lesion Location on Midterm Outcomes in Patients Undergoing Left Internal Mammary Artery Grafting: A Five-Year Cohort Study Integrating Quantitative Flow Ratio Assessment

Provisionally accepted
Ziang  SunZiang Sun1Yuhui  WuYuhui Wu1Rui  JiangRui Jiang2Zeyu  ChenZeyu Chen2Tianyu  WangTianyu Wang3Wenlong  YanWenlong Yan1*Sumin  YangSumin Yang1*
  • 1Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China
  • 2Department of DSA Room, The Affiliated Hospital of Qingdao University, Qingdao, China
  • 3School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong Province, China

The final, formatted version of the article will be published soon.

The prognostic value of coronary artery bypass grafting (CABG) may be suboptimal when guided solely by anatomical stenosis severity. Quantitative flow ratio (QFR), a computational angiography-derived hemodynamic assessment tool, offers functional insights; however, its prognostic interplay with lesion localization (proximal vs. mid-to-distal left anterior descending artery [LAD]) remains unclear. This study evaluates the impact of QFR-guided revascularization, stratified by LAD lesion location, on midterm clinical outcomes.A retrospective cohort of 481 patients undergoing left internal mammary artery (LIMA) to LAD grafting (2019-2023) was analyzed. Lesions were classified as proximal (Site 1) or mid-todistal (Site 2) LAD and stratified by QFR thresholds (High: ≥0.80; Low: <0.80). The primary endpoint was 5-year major adverse cardiovascular and cerebrovascular events (MACCEs), assessed using Kaplan-Meier survival analysis and Cox regression.Results: High QFR patients (n=139) exhibited lower diabetes (28.1% vs. 40.6%, p=0.013), smoking rates (27.3% vs. 38.6%, p=0.025), and 3-vessel disease (48.9% vs. 74.6%, p<0.0001) compared to low QFR (n=342). Proximal lesions with low high QFR had markedly higher MACCEs risk (HR=1.91, 95% CI:1.18-3.10; Log-rank P=0.0075), whereas mid-to-distal lesions showed no QFR-设置了格式: 上标 设置了格式: 字体: 非加粗 driven prognostic differences (p=0.46). Lesion location alone did not independently influence survival (Log-rank P=0.8).QFR-guided risk stratification is most prognostically impactful for proximal LAD lesions, where hemodynamic significance plays a critical role in clinical outcomes. In contrast, midto-distal lesions exhibit limited QFR utility, emphasizing anatomical-functional synergy in CABG planning. Despite comparable survival across lesion sites, proximal low QFR lesions warrant intensified surveillance.

Keywords: Quantitative flow ratio (QFR), Coronary Artery Bypass Grafting (CABG), Left anterior descending artery (LAD), Lesion localization, Angiography

Received: 03 Apr 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Sun, Wu, Jiang, Chen, Wang, Yan and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Wenlong Yan, Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China
Sumin Yang, Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.